The Heart Institute at Largo
Largo, Florida, United States
Cardiologist in Largo, Florida
1345 W Bay Dr Suite 101, Largo, FL 33770
About The Heart Institute at Largo
"The Heart Institute at Largo is now HCA Florida Heart Institute - Largo. Our cardiologists offer many programs, services and interventions to treat cardiovascular disease, from cholesterol testing to our coumadin clinic. We have highly-trained specialists and medical staff covering a full spectrum of cardiovascular medicine that includes cutting edge technologies, advanced research and the development of preventive and educational services. HCA Florida Heart Institute has established itself as a Center of Excellence by the American College of Cardiology for the care and treatment of cardiovascular disease."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Heart Institute at Largo
During the past decade, The Heart Institute at Largo conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)
2010-08-01
2013-08-01
Completed
173
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
2010-09-16
2019-02-14
Completed
1,717
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
2011-09-21
2024-06-30
Active, not recruiting
118
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
2012-05-01
2031-03-01
Active, not recruiting
504
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure
2013-02-01
2015-08-01
Completed
203
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The Heart Institute at Largo
According to Clinical.Site data, the most researched conditions in "The Heart Institute at Largo" are
"Cardiovascular Disease" (2 trials), "Heart Failure" (1 trials), "Paroxysmal Atrial Fibrillation" (1 trials) and "Ventricular Arrhythmia" (1 trials). Many other conditions were trialed in "The Heart Institute at Largo" in a lesser frequency.
Clinical Trials Intervention Types at The Heart Institute at Largo
Most popular intervention types in "The Heart Institute at Largo" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "BMS-919373" (1 trials), "Eleclazine" (1 trials) and "Placebo (Matching with BMS-919373)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Heart Institute at Largo
The vast majority of trials in "The Heart Institute at Largo" are
5 trials for "All" genders.
Clinical Trials Status at The Heart Institute at Largo
Currently, there are NaN active trials in "The Heart Institute at Largo".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in The Heart Institute at Largo,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in The Heart Institute at Largo, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".